Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Trocchi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
BMC Cancer|November 27, 2012
Mammographic density and inter-observer variability of pathologic evaluation of core biopsies among women with mammographic abnormalitiesPietro Trocchi, Giske Ursin, Oliver Kuss, et al.
Histopathology|November 19, 2011
Factors influencing the agreement on histopathological assessments of breast biopsies among pathologistsAndreas Stang, Pietro Trocchi, Kathrin Ruschke, et al.
Virchows Archiv : an International Journal of Pathology|July 7, 2021
Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotypingAndré Fehr, Sarah Werenicz, Pietro Trocchi, et al.
BMC Cancer|December 1, 2014
The prevalence of estrogen receptor-negative breast cancer in EthiopiaEva Johanna Kantelhardt, Assefa Mathewos, Abreha Aynalem, et al.
BMC Cancer|June 16, 2007
Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS)Alexander Kluttig, Pietro Trocchi, Anke Heinig, et al.
The Oncologist|June 22, 2014
Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapyEva Johanna Kantelhardt, Ulrike Moelle, Matthias Begoihn, et al.
European Journal of Endocrinology|February 4, 2026
Endocrine and metabolic late effects in childhood cancer survivors in Germany: the VersKiK studyPietro Trocchi, Enno Swart, Ekaterina Aleshchenko, et al.
European Journal of Endocrinology|January 19, 2026
Endocrine and metabolic late-effects in childhood cancer survivors in Germany: the VersKiK-StudyPietro Trocchi, Enno Swart, Ekaterina Aleshchenko, et al.
Deutsches Arzteblatt International|April 6, 2026
Heart Disease in Survivors of Childhood Cancer: Data From the German Cancer Registry and Statutory Health Insurance Carriers (the VersKiK Study)Hiltrud Merzenich, Pietro Trocchi, Claudia Bremensdorfer, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|March 25, 2025
[Recruitment of a cohort to investigate medical follow-up care after childhood cancer: Record-Linkage between the German Childhood Cancer Registry and statutory health insurance companies (VersKiKCohort)]Hiltrud Merzenich, Peter Ihle, Jutta Küpper-Nybelen, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
BMC Cancer|November 27, 2012
Mammographic density and inter-observer variability of pathologic evaluation of core biopsies among women with mammographic abnormalitiesPietro Trocchi, Giske Ursin, Oliver Kuss, et al.
Histopathology|November 19, 2011
Factors influencing the agreement on histopathological assessments of breast biopsies among pathologistsAndreas Stang, Pietro Trocchi, Kathrin Ruschke, et al.
Virchows Archiv : an International Journal of Pathology|July 7, 2021
Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotypingAndré Fehr, Sarah Werenicz, Pietro Trocchi, et al.
BMC Cancer|December 1, 2014
The prevalence of estrogen receptor-negative breast cancer in EthiopiaEva Johanna Kantelhardt, Assefa Mathewos, Abreha Aynalem, et al.
BMC Cancer|June 16, 2007
Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS)Alexander Kluttig, Pietro Trocchi, Anke Heinig, et al.
The Oncologist|June 22, 2014
Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapyEva Johanna Kantelhardt, Ulrike Moelle, Matthias Begoihn, et al.
European Journal of Endocrinology|February 4, 2026
Endocrine and metabolic late effects in childhood cancer survivors in Germany: the VersKiK studyPietro Trocchi, Enno Swart, Ekaterina Aleshchenko, et al.
European Journal of Endocrinology|January 19, 2026
Endocrine and metabolic late-effects in childhood cancer survivors in Germany: the VersKiK-StudyPietro Trocchi, Enno Swart, Ekaterina Aleshchenko, et al.
Deutsches Arzteblatt International|April 6, 2026
Heart Disease in Survivors of Childhood Cancer: Data From the German Cancer Registry and Statutory Health Insurance Carriers (the VersKiK Study)Hiltrud Merzenich, Pietro Trocchi, Claudia Bremensdorfer, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|March 25, 2025
[Recruitment of a cohort to investigate medical follow-up care after childhood cancer: Record-Linkage between the German Childhood Cancer Registry and statutory health insurance companies (VersKiKCohort)]Hiltrud Merzenich, Peter Ihle, Jutta Küpper-Nybelen, et al.
Pageof 3